Literature DB >> 23501398

Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Shradha Agarwal1, Lloyd Mayer.   

Abstract

Gastrointestinal disorders such as chronic or acute diarrhea, malabsorption, abdominal pain, and inflammatory bowel diseases can indicate immune deficiency. The gastrointestinal tract is the largest lymphoid organ in the body, so it is not surprising that intestinal diseases are common among immunodeficient patients. Gastroenterologists therefore must be able to diagnose and treat patients with primary immunodeficiency. Immune-related gastrointestinal diseases can be classified as those that develop primarily via autoimmunity, infection, an inflammatory response, or malignancy. Immunodeficient and immunocompetent patients with gastrointestinal diseases present with similar symptoms. However, intestinal biopsy specimens from immunodeficient patients often have distinct histologic features, and these patients often fail to respond to conventional therapies. Therefore, early recognition of symptoms and referral to an immunologist for a basic immune evaluation is required to select appropriate treatments. Therapies for primary immunodeficiency comprise immunoglobulin replacement, antibiotics, and, in severe cases, bone marrow transplantation. Treatment of immunodeficient patients with concomitant gastrointestinal disease can be challenging, and therapy with immunomodulators often is required for severe disease. This review aims to guide gastroenterologists in the diagnosis and treatment of patients with primary immunodeficiency.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-MP; AZA; CGD; CVID; FOXP3; GI; GVHD; Hypogammaglobulinemia; IBD; IL; IPEX; Ig; Immune System; Inflammatory Intestinal Disease; NLH; SCID; STAT; TNF; WAS; WASp; Wiskott–Aldrich syndrome; Wiskott–Aldrich syndrome protein; X-linked agammaglobulinemia; XLA; azathioprine; chronic granulomatous disease; common variable immunodeficiency; forkhead box P3; gastrointestinal; graft-versus-host disease; immune dysfunction, polyendocrinopathy, enteropathy, X-linked; immunoglobulin; inflammatory bowel disese; interleukin; mercaptopurine; nodular lymphoid hyperplasia; severe combined immunodeficiency; signal transducer and activator of transcription; tumor necrosis factor

Mesh:

Year:  2013        PMID: 23501398      PMCID: PMC3800204          DOI: 10.1016/j.cgh.2013.02.024

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  162 in total

1.  Clinical spectrum of X-linked hyper-IgM syndrome.

Authors:  J Levy; T Espanol-Boren; C Thomas; A Fischer; P Tovo; P Bordigoni; I Resnick; A Fasth; M Baer; L Gomez; E A Sanders; M D Tabone; D Plantaz; A Etzioni; V Monafo; M Abinun; L Hammarstrom; T Abrahamsen; A Jones; A Finn; T Klemola; E DeVries; O Sanal; M C Peitsch; L D Notarangelo
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  Inflammatory papillary stenosis due to Giardia lamblia in a patient with hyper-immunoglobulin M immunodeficiency syndrome.

Authors:  Vikram Bhatia; Pramod Kumar Garg; Vikas Agarwal; Manik Sharma; Samant Ray
Journal:  Gastrointest Endosc       Date:  2007-07       Impact factor: 9.427

3.  Hepatic abscess in patients with chronic granulomatous disease.

Authors:  Matthew Lublin; David L Bartlett; David N Danforth; Howard Kauffman; John I Gallin; Harry L Malech; Thomas Shawker; Peter Choyke; David E Kleiner; Douglas J Schwartzentruber; Richard Chang; Ellen S DeCarlo; Steven M Holland
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Adult celiac disease (celiac sprue), pernicious anemia and IgA deficiency. Case report and review of the relationships between vitamin B12 deficiency, small intestinal mucosal disease and immunoglobulin deficiency.

Authors:  E M Quigley; H A Carmichael; G Watkinson
Journal:  J Clin Gastroenterol       Date:  1986-06       Impact factor: 3.062

5.  Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome.

Authors:  E Levy-Lahad; R S Wildin
Journal:  J Pediatr       Date:  2001-04       Impact factor: 4.406

6.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

7.  Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).

Authors:  Lutz Bindl; Troy Torgerson; Lucia Perroni; Nelly Youssef; Hans D Ochs; Olivier Goulet; Frank M Ruemmele
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

8.  Coexisting primary malignant lymphoma and adenocarcinoma of the large intestine in an IgA-deficient boy.

Authors:  S H Mir-Madjlessi; M Vafai; J Khademi; N Kamalian
Journal:  Dis Colon Rectum       Date:  1984-12       Impact factor: 4.585

9.  Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

Authors:  Hulya Ozsahin; Marina Cavazzana-Calvo; Luigi D Notarangelo; Ansgar Schulz; Adrian J Thrasher; Evelina Mazzolari; Mary A Slatter; Francoise Le Deist; Stephane Blanche; Paul Veys; Anders Fasth; Robbert Bredius; Petr Sedlacek; Nico Wulffraat; Juan Ortega; Carsten Heilmann; Anne O'Meara; Jacek Wachowiak; Krzysztof Kalwak; Susanne Matthes-Martin; Tayfun Gungor; Aydan Ikinciogullari; Paul Landais; Andrew J Cant; Wilhelm Friedrich; Alain Fischer
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  61 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  Autoimmunity in common variable immunodeficiency.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2019-07-23       Impact factor: 6.347

3.  Common Variable Immunodeficiency-Associated Inflammatory Enteropathy: The New Era of Biological Therapy.

Authors:  Cátia Arieira; Francisca Dias de Castro; Maria João Moreira; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2018-02-13

Review 4.  Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature.

Authors:  Antonio Pecoraro; Liliana Nappi; Ludovica Crescenzi; Francesco P D'Armiento; Arturo Genovese; Giuseppe Spadaro
Journal:  J Clin Immunol       Date:  2017-11-14       Impact factor: 8.317

Review 5.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

6.  Elevated plasma catecholamines functionally compensate for the reduced myogenic tone in smooth muscle STIM1 knockout mice but with deleterious cardiac effects.

Authors:  Prahalathan Pichavaram; Wen Yin; Kirk W Evanson; Jonathan H Jaggar; Salvatore Mancarella
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

Review 7.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 8.  Chronic norovirus infection and common variable immunodeficiency.

Authors:  J Woodward; E Gkrania-Klotsas; D Kumararatne
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

Review 9.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

Review 10.  Rheumatologic manifestations of primary immunodeficiency diseases.

Authors:  V R Dimitriades; R Sorensen
Journal:  Clin Rheumatol       Date:  2016-03-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.